Capital Investment Advisory Services, LLC Verastem, Inc. Transaction History

Capital Investment Advisory Services, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 28, 2021	SELL	$2.54 - $4.07 $29,210 - $46,805	-11,500 Closed	0 $0
Q3 2020 Oct 19, 2020	SELL	$1.11 - $1.68 $1,110 - $1,680	-1,000 Reduced 8.0%	11,500 $14,000
Q4 2019 Feb 04, 2020	BUY	$0.86 - $1.44 $4,558 - $7,632	5,300 Added 73.61%	12,500 $17,000
Q3 2019 Oct 17, 2019	SELL	$1.21 - $1.59 $2,057 - $2,703	-1,700 Reduced 19.1%	7,200 $9,000
Q2 2019 Aug 08, 2019	BUY	$1.25 - $3.14 $1,750 - $4,396	1,400 Added 18.67%	8,900 $12,000
Q1 2019 Apr 23, 2019	BUY	$2.79 - $4.09 $16,461 - $24,131	5,900 Added 368.75%	7,500 $22,000
Q4 2018 Feb 04, 2019	BUY	$3.23 - $7.01 $5,168 - $11,216	1,600 New	1,600 $5,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.25B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Capital Investment Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Investment Advisory Services, LLC with notifications on news.